Showing results (91-100 of 415) with videos related to

Sort By:
Pageof 42
Autoimmunity|January 1, 1990
Immunological abnormalities in a group of patients with limited cutaneous systemic sclerosis and prominent vascular diseaseA Passaleva, G Massai, M Matucci-Cerinic, et al.
Clinical Orthopaedics and Related Research|July 25, 1998
Macrophage activation results in bone resorptionJ Lassus, J Salo, W A Jiranek, et al.
Clinical Rheumatology|October 12, 2012
Bosentan fosters microvascular de-remodelling in systemic sclerosisS Guiducci, S Bellando Randone, C Bruni, et al.
British Journal of Rheumatology|August 1, 1990
Fibrinolytic activity in the synovial membrane of osteoarthritisM Matucci-Cerinic, A Lombardi, T Lotti, et al.
The Journal of Rheumatology|March 1, 1990
Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury?M Matucci-Cerinic, A Pignone, T Lotti, et al.
Clinical and Experimental Rheumatology|June 24, 2005
Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cellsS Guiducci, A Del Rosso, M Cinelli, et al.
Scandinavian Journal of Rheumatology|June 4, 2024
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohortN Farina, A Tomelleri, N Boffini, et al.
International Journal of Dermatology|May 1, 1993
Mesoglycan treatment restores defective fibrinolytic potential in cutaneous necrotizing venulitisT Lotti, G Celasco, D Tsampau, et al.
Rheumatology (Oxford, England)|December 26, 2008
Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodiesF Mecacci, B Bianchi, A Pieralli, et al.
International Journal of Dermatology|November 1, 1990
Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activationM Matucci-Cerinic, T Lotti, A Lombardi, et al.
Pageof 42